Morgan Dempsey Capital Management LLC Gilead Sciences, Inc. Transaction History

Morgan Dempsey Capital Management LLC

$298 Million
Q2 2024

A detailed history of Morgan Dempsey Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Morgan Dempsey Capital Management LLC holds 129,045 shares of GILD stock, worth $10.9 Million. This represents 2.97% of its overall portfolio holdings.

Number of Shares

129,045

Previous 134,210 3.85%

Holding current value

$10.9 Million

Previous $9.83 Million 9.94%

% of portfolio

2.97%

Previous 3.17%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$63.15 - $72.88 $326,169 - $376,425	-5,165 Reduced 3.85%	129,045 $8.85 Million
Q1 2024 May 02, 2024	SELL	$71.58 - $87.29 $1.19 Million - $1.45 Million	-16,637 Reduced 11.03%	134,210 $9.83 Million
Q4 2023 Jan 24, 2024	SELL	$73.27 - $83.09 $635,690 - $720,888	-8,676 Reduced 5.44%	150,847 $12.2 Million
Q3 2023 Oct 20, 2023	SELL	$73.94 - $80.67 $332,434 - $362,692	-4,496 Reduced 2.74%	159,523 $12 Million
Q2 2023 Jul 25, 2023	SELL	$76.01 - $86.7 $200,134 - $228,281	-2,633 Reduced 1.58%	164,019 $12.6 Million
Q1 2023 Apr 17, 2023	BUY	$77.31 - $88.08 $273,522 - $311,627	3,538 Added 2.17%	166,652 $13.8 Million
Q4 2022 Feb 03, 2023	BUY	$62.32 - $89.47 $336,839 - $483,585	5,405 Added 3.43%	163,114 $14 Million
Q3 2022 Oct 18, 2022	BUY	$59.54 - $68.01 $92,525 - $105,687	1,554 Added 1.0%	157,709 $9.73 Million
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $1.54 Million - $1.74 Million	26,721 Added 20.64%	156,155 $9.65 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $100,085 - $125,418	-1,728 Reduced 1.32%	129,434 $7.7 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $308,763 - $350,452	-4,759 Reduced 3.5%	131,162 $9.52 Million
Q3 2021 Nov 04, 2021	SELL	$67.69 - $73.03 $454,335 - $490,177	-6,712 Reduced 4.71%	135,921 $9.49 Million
Q2 2021 Jul 26, 2021	BUY	$63.47 - $69.35 $1.54 Million - $1.68 Million	24,218 Added 20.45%	142,633 $9.82 Million
Q1 2021 Apr 20, 2021	BUY	$60.0 - $68.46 $1.31 Million - $1.5 Million	21,906 Added 22.7%	118,415 $7.65 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $1.3 Million - $1.48 Million	-22,883 Reduced 19.17%	96,509 $5.62 Million
Q3 2020 Oct 26, 2020	BUY	$62.1 - $78.08 $365,210 - $459,188	5,881 Added 5.18%	119,392 $7.54 Million
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $517,954 - $601,440	7,160 Added 6.73%	113,511 $8.73 Million
Q1 2020 May 06, 2020	BUY	$62.63 - $80.22 $347,847 - $445,541	5,554 Added 5.51%	106,351 $7.95 Million
Q4 2019 Feb 05, 2020	BUY	$61.62 - $67.78 $3.35 Million - $3.69 Million	54,426 Added 117.37%	100,797 $6.55 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $155,899 - $172,086	2,494 Added 5.68%	46,371 $2.94 Million
Q2 2019 Aug 08, 2019	BUY	$61.87 - $69.38 $195,199 - $218,893	3,155 Added 7.75%	43,877 $2.96 Million
Q1 2019 May 08, 2019	BUY	$62.53 - $70.05 $2.55 Million - $2.85 Million	40,722 New	40,722 $2.65 Million

Others Institutions Holding GILD

# of Institutions

1,880

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Dempsey Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Dempsey Capital Management LLC with notifications on news.

Account

Morgan Dempsey Capital Management LLC Gilead Sciences, Inc. Transaction History